Anionic polymer-coated lipoplex for safe gene delivery into tumor by systemic injection

Journal of Drug Targeting

Volumn 21, Issue 7, 2013, Pages 639-647

  Hattori, Yoshiyuki ^a   Yamasaku, Haruka ^a   Maitani, Yoshie ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Anionic polymer; Chondroitin sulfate; Gene delivery; Hyaluronan; Liposome; Poly l glutamic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ANIONIC POLYMER COATED LIPOPLEX; ASPARTATE AMINOTRANSFERASE; CHONDROITIN 6 SULFATE; HYALURONIC ACID; LIPOPLEX; PLASMID DNA; POLYGLUTAMIC ACID; POLYMER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; ENDOCYTOSIS; ERYTHROCYTE; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GEL ELECTROPHORESIS; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; IN VITRO GENE TRANSFER; INJECTION; LIVER; LIVER TOXICITY; LUNG; MOUSE; NEOPLASM; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

ANIMALS; ANIONS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; LIPOSOMES; MICE; NEOPLASMS; POLYMERS;

EID: 84880567137     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.789035     Document Type: Article

References (35)

1. Dachs GU, Dougherty GJ, Stratford IJ, Chaplin DJ. Targeting gene therapy to cancer: A review. Oncol Res 1997;9:313-25
2. Morille M, Passirani C, Vonarbourg A, et al. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008;29:3477-96
3. Bragonzi A, Dina G, Villa A, et al. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther 2000;7:1753-60
4. Yeeprae W, Kawakami S, Suzuki S, et al. Physicochemical and pharmacokinetic characteristics of cationic liposomes. Pharmazie 2006;61:102-5
5. Hong K, Zheng W, Baker A, Papahadjopoulos D. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett 1997;400:233-7
6. Song YK, Liu D. Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intravenous administration. Biochim Biophys Acta 1998;1372:141-50
7. Zhu N, Liggitt D, Liu Y, Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993;261: 209-11
8. Eliyahu H, Servel N, Domb AJ, Barenholz Y. Lipoplex-induced hemagglutination: Potential involvement in intravenous gene delivery. Gene Ther 2002;9:850-8
9. Simberg D, Weisman S, Talmon Y, et al. The role of organ vascularization and lipoplex-serum initial contact in intravenous murine lipofection. J Biol Chem 2003;278:39858-65
10. Gjetting T, Arildsen NS, Christensen CL, et al. In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/ cholesterol-mediated gene transfection. Int J Nanomedicine 2010;5: 371-83
11. Ito T, Iida-Tanaka N, Koyama Y. Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid. J Drug Target 2008;16:276-81
12. Kurosaki T, Kitahara T, Fumoto S, et al. Chondroitin sulfate capsule system for efficient and secure gene delivery. J Pharm Pharm Sci 2010;13:351-61
13. Kurosaki T, Kitahara T, Kawakami S, et al. Gamma-polyglutamic acid-coated vectors for effective and safe gene therapy. J Control Release 2010;142:404-10
14. Bagari R, Bansal D, Gulbake A, et al. Chondroitin sulfate functionalized liposomes for solid tumor targeting. J Drug Target 2011;19:251-7
15. Song YK, Liu F, Chu S, Liu D. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther 1997;8:1585-94
16. Templeton NS, Lasic DD, Frederik PM, et al. Improved DNA: Liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 1997;15:647-52
17. Lu C, Stewart DJ, Lee JJ, et al. Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One 2012;7:e34833
18. Kato M, Hattori Y, Kubo M, Maitani Y. Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex. Int J Pharm 2012;423:428-34
19. Igarashi S, Hattori Y, Maitani Y. Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome. J Control Release 2006;112:362-8
20. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13:238-52
21. Hattori Y, Ding WX, Maitani Y. Highly efficient cationic hydroxyethylated cholesterol-based nanoparticle-mediated gene transfer in vivo and in vitro in prostate carcinoma PC-3 cells. J Control Release 2007;120:122-30
22. Duarte S, Faneca H, Lima MC. Non-covalent association of folate to lipoplexes: A promising strategy to improve gene delivery in the presence of serum. J Control Release 2011;149:264-72
23. Hattori Y, Maitani Y. Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther 2005;12:796-809
24. Loisel S, Floch V, Le GC, Ferec C. Factors influencing the efficiency of lipoplexes mediated gene transfer in lung after intravenous administration 1. J Liposome Res 2001;11:127-38
25. Zhang Y, Bradshaw-Pierce EL, Delille A, et al. In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: Effects on biodistribution and tumor accumulation. J Pharm Sci 2008;97:237-50
26. Ghosh SC, Neslihan AS, Klostergaard J. CD44: A validated target for improved delivery of cancer therapeutics. Expert Opin Ther Targets 2012;16:635-50
27. Negi LM, Talegaonkar S, Jaggi M, et al. Role of CD44 in tumour progression and strategies for targeting. J Drug Target 2012;20: 561-73
28. Loisel S, Le GC, Doucet L, et al. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum Gene Ther 2001;12:685-96
29. Mitsui M, Nishikawa M, Zang L, et al. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression. J Gene Med 2009;11:435-43
30. Auzenne E, Ghosh SC, Khodadadian M, et al. Hyaluronic acidpaclitaxel: Antitumor efficacy against CD44(T) human ovarian carcinoma xenografts. Neoplasia 2007;9:479-86
31. Zhang L, Yao J, Zhou J, Wang T, Zhang Q. Glycyrrhetinic acidgraft- hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs. Int J Pharm 2013;441:654-64
32. Galic VL, Herzog TJ, Wright JD, Lewin SN. Paclitaxel poliglumex for ovarian cancer. Expert Opin Investig Drugs 2011;20:813-21
33. Ito T, Yoshihara C, Hamada K, Koyama Y. DNA/polyethyleneimine/ hyaluronic acid small complex particles and tumor suppression in mice. Biomaterials 2010;31:2912-8
34. Thurston G, McLean JW, Rizen M, et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest 1998;101:1401-3
35. Krasnici S, Werner A, Eichhorn ME, et al. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int J Cancer 2003;105:561-7 Culture, Sports, Science, and Technology of Japan